Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Atea Pharmaceuticals Inc (AVIR)

Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atea Pharmaceuticals Inc 225 Franklin Street Suite 2100 BOSTON MA 02110 USA

www.ateapharma.com Employees: 55 P: 857-284-8891

Sector:

Medical

Description:

Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 489,983
Enterprise Value, $K 394,273
Shares Outstanding, K 79,672
Float, K 65,251
% Float 81.90%
Short Interest, K 7,721
Short Float 9.88%
Days to Cover 14.77
Short Volume Ratio 0.37
% of Insider Shareholders 18.10%
% of Institutional Shareholders 86.67%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -158,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -44,870 K
EBIT, $ -180,890 K
EBITDA, $ -185,420 K

Growth:

1-Year Return 113.18%
3-Year Return 63.13%
5-Year Return -92.12%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -280.39%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.53 on 11/12/25
Next Earnings Date 05/11/26
Earnings Per Share ttm -1.94
EPS Growth vs. Prev Qtr -7.55%
EPS Growth vs. Prev Year -42.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

AVIR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.34%
Return-on-Assets % -42.52%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.67
Book Value/Share 3.53
Interest Coverage -4.01
60-Month Beta 0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar